Erler JT - Search Results

1

Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients.

Liu N, Cox TR, Cui W, Adell G, Holmlund B, Ping J, Jarlsfelt I, Erler JT, Sun XF. Liu N, et al. Among authors: erler jt. Oncotarget. 2016 May 26;8(36):60015-60024. doi: 10.18632/oncotarget.9623. eCollection 2017 Sep 1. Oncotarget. 2016. PMID: 28947950 Free PMC article.

2

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ. Erler JT, et al. Cancer Cell. 2009 Jan 6;15(1):35-44. doi: 10.1016/j.ccr.2008.11.012. Cancer Cell. 2009. PMID: 19111879 Free PMC article.

3

LOXL2-mediated matrix remodeling in metastasis and mammary gland involution.

Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, Evans HR, Gartland A, Erler JT. Barker HE, et al. Among authors: erler jt. Cancer Res. 2011 Mar 1;71(5):1561-72. doi: 10.1158/0008-5472.CAN-10-2868. Epub 2011 Jan 13. Cancer Res. 2011. PMID: 21233336 Free PMC article.

4

The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.

Baker AM, Cox TR, Bird D, Lang G, Murray GI, Sun XF, Southall SM, Wilson JR, Erler JT. Baker AM, et al. Among authors: erler jt. J Natl Cancer Inst. 2011 Mar 2;103(5):407-24. doi: 10.1093/jnci/djq569. Epub 2011 Jan 31. J Natl Cancer Inst. 2011. PMID: 21282564

5

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.

Cox TR, Erler JT. Cox TR, et al. Among authors: erler jt. Dis Model Mech. 2011 Mar;4(2):165-78. doi: 10.1242/dmm.004077. Epub 2011 Feb 14. Dis Model Mech. 2011. PMID: 21324931 Free PMC article.

6

Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK.

Baker AM, Bird D, Lang G, Cox TR, Erler JT. Baker AM, et al. Among authors: erler jt. Oncogene. 2013 Apr 4;32(14):1863-8. doi: 10.1038/onc.2012.202. Epub 2012 May 28. Oncogene. 2013. PMID: 22641216

7

The rationale for targeting the LOX family in cancer.

Barker HE, Cox TR, Erler JT. Barker HE, et al. Among authors: erler jt. Nat Rev Cancer. 2012 Jul 19;12(8):540-52. doi: 10.1038/nrc3319. Nat Rev Cancer. 2012. PMID: 22810810 Review.

8

Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis.

Baker AM, Bird D, Welti JC, Gourlaouen M, Lang G, Murray GI, Reynolds AR, Cox TR, Erler JT. Baker AM, et al. Among authors: erler jt. Cancer Res. 2013 Jan 15;73(2):583-94. doi: 10.1158/0008-5472.CAN-12-2447. Epub 2012 Nov 27. Cancer Res. 2013. PMID: 23188504 Free PMC article.

9

LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis.

Cox TR, Bird D, Baker AM, Barker HE, Ho MW, Lang G, Erler JT. Cox TR, et al. Among authors: erler jt. Cancer Res. 2013 Mar 15;73(6):1721-32. doi: 10.1158/0008-5472.CAN-12-2233. Epub 2013 Jan 23. Cancer Res. 2013. PMID: 23345161 Free PMC article.

10

LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.

Chang J, Nicolau MM, Cox TR, Wetterskog D, Martens JW, Barker HE, Erler JT. Chang J, et al. Among authors: erler jt. Breast Cancer Res. 2013;15(4):R67. doi: 10.1186/bcr3461. Breast Cancer Res. 2013. PMID: 23971878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page